# Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry

> **NCT03603275** · — · TERMINATED · sponsor: **Bayer** · enrollment: 3 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** New FVIII products

## Key facts

- **NCT ID:** NCT03603275
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-06
- **Primary completion:** 2020-05-14
- **Final completion:** 2020-05-14
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Insufficient data
- **Last updated:** 2022-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603275, "Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03603275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*